Immunity for Health: Vaccines & Immunotherapy

16–17 Oct 2024 | RodeBol Events

Rein Verbeke

postdoc

Ghent University - NM center

Gent, Belgium

4 profile visitsSpeaker

Research focus is on mRNA vaccines. Happy to help with the development and characterization of mRNA-LNP vaccines or other types of nanovaccines.

About me

Dr. Rein Verbeke is a senior postdoc in the Ghent Research Group on Nanomedicines (Ghent University). His PhD focused on the design of mRNA-LNPs and the adjuvancy of mRNA vaccines. Rein continued his research on the validation of a glycolipid-adjuvanted mRNA vaccine (Galsomes) for cancer and intracellular bacterial infections. In 2022, he visited the group of Prof. Pieter Cullis, University of British Columbia, where he investigated the contribution of LNPs to the immunogenicity and reactogenicity of mRNA vaccines. Rein is also director of the Ghent Nanomedicine Center providing solutions for the formulation and in-depth characterization of bio-therapeutics in nanoparticles.

My organisation

Ghent University - NM center

https://www.drugdelivery.be/nmc/

Ghent NanoMedicine center offers cutting-edge pharmaceutical expertise and infrastructure to academic and industrial partners for the formulation of bio-therapeutics in nanoparticles from early discovery into first-in-human clinical trials, including for mRNA vaccine development.

Social media

Skills

  • preclinical testing
  • Analytical methods
  • mRNA vaccine design

Interests

  • mRNA
  • LNP
  • cancer vaccines

Additional questions

How would you categorise yourself?

ResearcherProject manager

Organisation Type

Academic institution

Areas of expertise

Preclinical research Immunotherapy R&DCell and Gene therapyVaccine R&DImmuno-oncology

Therapeutic areas

Infectious diseases Oncology

1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.

I agree

Speaker sessions (1)

Thursday, 17 October 2024

Speaker presentation

Download speaker presentation